Tessera Therapeutics focuses on genetic medicine, utilizing a technology called Gene Writing to make precise changes to the human genome. This technology allows for permanent alterations to genetic material in any cell, which can potentially cure diseases at their source. The Gene Writing platform can perform both small and large genetic modifications, making it applicable to a wide range of genetic disorders. Tessera Therapeutics collaborates with research institutions, pharmaceutical companies, and healthcare providers to develop new treatments for genetic diseases. Unlike many competitors, Tessera's approach emphasizes the ability to address previously untreatable conditions through its proprietary technology. The company's goal is to advance the development of Gene Writing to ultimately cure diseases by rewriting the genetic code.